Items where authors include "Chan, A."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Coates, L.C., Bukhari, M., Chan, A. et al. (9 more authors) (2024) Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel. Rheumatology. keae172. ISSN 1462-0324
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Nield, L. orcid.org/0000-0003-2072-6602, Thelwell, M. orcid.org/0000-0003-0145-0452, Chan, A. et al. (2 more authors) (2024) Patient perceptions of three-dimensional (3D) surface imaging technology and traditional methods used to assess anthropometry. Obesity Pillars, 9. 100100. ISSN 2667-3681
Perneczky, R. orcid.org/0000-0003-1981-7435, Dom, G., Chan, A. et al. (2 more authors) (2024) Anti‐amyloid antibody treatments for Alzheimer's disease. European Journal of Neurology, 31 (2). e16049. ISSN 1351-5101
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Adisa, A., Bahrami-Hessari, M., Bhangu, A. orcid.org/0000-0001-5999-4618 et al. (2460 more authors) (2023) Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries. British Journal of Surgery, 110 (7). pp. 804-817. ISSN 0007-1323
Adisa, A., Bahrami-Hessari, M., Bhangu, A. et al. (1891 more authors) (2023) Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries. British Journal of Surgery, 110 (7). pp. 804-817. ISSN 0007-1323
Chan, V.W.S. orcid.org/0000-0002-6108-9315, Rahman, L., Ng, H.H. et al. (12 more authors) (2023) Mitigation of COVID-19 transmission in endoscopic and surgical aerosol-generating procedures: a narrative review of early-pandemic literature. Hong Kong Medical Journal, 29 (3). pp. 247-255. ISSN 1024-2708
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Coleman, R. orcid.org/0000-0002-4275-1043, Finkelstein, D.M., Barrios, C. et al. (14 more authors) (2020) Adjuvant denosumab in early breast cancer (D-CARE) : an international, multicentre, randomised, controlled, phase 3 trial. The Lancet Oncology, 21 (1). pp. 60-72. ISSN 1470-2045